BioSenic S.A. (EBR:BIOS)

BioSenic Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.82	0.12	1.85	0.76
Cash & Short-Term Investments	0.82	0.12	1.85	0.76
Cash Growth	57.23%	-93.66%	143.22%	-
Accounts Receivable	0.27	0.14	-	-
Other Receivables	1.06	1.32	2.49	0.36
Receivables	1.34	1.46	2.49	0.36
Other Current Assets	0.44	0.27	0.29	0
Total Current Assets	2.59	1.85	4.63	1.12
Property, Plant & Equipment	0.59	0.7	1.42	0.01
Long-Term Investments	0.01	0.01	0.01	-
Goodwill	-	-	1.8	-
Other Intangible Assets	2.98	2.99	17.29	-
Long-Term Accounts Receivable	0.32	0.4	-	-
Other Long-Term Assets	2.9	3.62	4.17	0.03
Total Assets	9.4	9.56	29.32	1.16
Accounts Payable	2.6	3.87	2.24	0.21
Current Portion of Long-Term Debt	3.08	11.82	8.01	1.25
Current Income Taxes Payable	-	0.01	-	-
Other Current Liabilities	0.32	0.15	0.1	0.03
Total Current Liabilities	6.49	15.84	10.35	1.49
Long-Term Debt	22.61	16.34	15.78	2.27
Other Long-Term Liabilities	0.08	0.08	0.07	0.07
Total Liabilities	29.8	32.26	26.2	3.83
Common Stock	8.18	6.28	4.77	0.66
Additional Paid-In Capital	5.84	5.72	4.52	3.97
Retained Earnings	-34.4	-34.89	-5.72	-7.22
Comprehensive Income & Other	-0.08	-0.02	-0.04	-0.08
Total Common Equity	-20.47	-22.91	3.53	-2.67
Minority Interest	0.06	0.21	-0.4	-
Shareholders' Equity	-20.4	-22.71	3.12	-2.67
Total Liabilities & Equity	9.4	9.56	29.32	1.16
Total Debt	26.79	28.16	23.79	3.53
Net Cash (Debt)	-25.98	-28.04	-21.95	-2.77
Net Cash Per Share	-0.15	-0.20	-0.14	-41.86
Filing Date Shares Outstanding	251.31	149.58	152.45	0.07
Total Common Shares Outstanding	251.31	149.58	152.45	0.07
Working Capital	-3.9	-14	-5.73	-0.37
Book Value Per Share	-0.08	-0.15	0.02	-40.40
Tangible Book Value	-23.45	-25.9	-15.57	-2.67
Tangible Book Value Per Share	-0.09	-0.17	-0.10	-40.40

Updated Sep 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.